Cargando…
TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma
AAA-ATPase TRIP13 is one of the chromosome instability gene recently established in multiple myeloma (MM), the second most common and incurable hematological malignancy. However, the specific function of TRIP13 in MM is largely unknown. Using sequential gene expression profiling, we demonstrated tha...
Autores principales: | Tao, Yi, Yang, Guang, Yang, Hongxing, Song, Dongliang, Hu, Liangning, Xie, Bingqian, Wang, Houcai, Gao, Lu, Gao, Minjie, Xu, Hongwei, Xu, Zhijian, Wu, Xiaosong, Zhang, Yiwen, Zhu, Weiliang, Zhan, Fenghuang, Shi, Jumei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432292/ https://www.ncbi.nlm.nih.gov/pubmed/28157697 http://dx.doi.org/10.18632/oncotarget.14957 |
Ejemplares similares
-
Overexpression of RPS27a contributes to enhanced chemoresistance of CML cells to imatinib by the transactivated STAT3
por: Wang, Houcai, et al.
Publicado: (2016) -
A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe
por: Hu, Liangning, et al.
Publicado: (2020) -
Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma
por: Gao, Minjie, et al.
Publicado: (2017) -
Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma
por: Gao, Minjie, et al.
Publicado: (2016) -
Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I
por: Yang, Guang, et al.
Publicado: (2015)